Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Technology and Code

Published on 26 Mar 2025

Integrating WHO’s digital adaptation kit for antenatal care into BornFyne-PNMS: insights from Cameroon

in Drugs Outcomes Research and Policies

Miriam Nkangu
Brice Tangang
Arthur Pessa
Donald Weledji
Pamela Obegu
Mwenya Kasonde
Ngo V. Ngo
Franck Wanda
Ronald M. Gobina
Odette Kibu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1474999

519 views

Original Research

Published on 26 Mar 2025

Reform progress and achievements of China’s incentive policies for pediatric medicine over the last decade

in Drugs Outcomes Research and Policies

Qiwei Wang
Xing Ling
Zhengli Dai
Xiaoling Wang
Wen Guo
Guiliang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561095

364 views

Brief Research Report

Published on 25 Mar 2025

Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis

in Drugs Outcomes Research and Policies

Borja G. Lopez-Rey
Gerard Carot-Sans
Dan Ouchi
Ferran Torres
Caridad Pontes

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548997

790 views

Original Research

Accepted on 21 Mar 2025

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for patients with unresectable hepatocellular carcinoma: A cost-utility analysis in China and the United States

in Drugs Outcomes Research and Policies

Qiuling Zhao
Yimin He
Zilin Nian
Liangliang Dong
Yongjian Huang
Ruyi Huang
Lijun Lai
Lin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1404389

126 views

Original Research

Published on 19 Mar 2025

Cost-effectiveness analysis of penpulimab combined with paclitaxel and carboplatin as first-line treatment for advanced squamous non-small cell lung cancer

in Drugs Outcomes Research and Policies

Xiaoyan You
Jiali Qin
Xiaomei Wang
Xianying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563788

639 views

Original Research

Published on 18 Mar 2025

Substandard antibiotics and their clinical outcomes among hospitalized patients in southern Malawi: a pilot study

in Drugs Outcomes Research and Policies

Francis Kachidza Chiumia
Adamson Sinjani Muula
Frider Chimimba
Happy Magwaza Nyirongo
Elizabeth Kampira
Felix Khuluza

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535501

486 views

Original Research

Published on 18 Mar 2025

Association of rivaroxaban plasma trough concentrations with clinical characteristics and outcomes

in Drugs Outcomes Research and Policies

Huizhen Wu
Qiaoling Yu
Panpan Jin
Lijing Huo
Jing An

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563745

482 views

Original Research

Published on 14 Mar 2025

Unaware and unpowered: evaluating patient perceptions and preferences of biosimilars in South Korea

in Drugs Outcomes Research and Policies

Eunjung Choi
Gyeongseon Shin
SeungJin Bae

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551451

459 views

Original Research

Published on 14 Mar 2025

Pharmacist-led surgical medicines prescription optimization and prediction service improves patient outcomes - a machine learning based study

in Drugs Outcomes Research and Policies

Xianlin Li
Xiunan Yue
Lan Zhang
Xiaojun Zheng
Nan Shang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534552

445 views

Original Research

Published on 11 Mar 2025

Cost-effectiveness analysis of enzyme replacement therapy for the treatment of Chinese patients with fabry disease: a Markov model

in Drugs Outcomes Research and Policies

Yueyang Huang
Hongmei Yuan
Zhe Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546018

443 views

Original Research

Published on 11 Mar 2025

Differences in risk factors for mortality between T2N1M0 and T3N0M0 lobular breast cancer patients: a comparative study

in Drugs Outcomes Research and Policies

Longjie Xia
Chunxin Qin
Wei Chen
Kang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1550081

468 views

Review

Published on 10 Mar 2025

Effects of perioperative anesthetics on the postoperative prognosis of patients undergoing surgery for cervical cancer

in Drugs Outcomes Research and Policies

Linyan Deng
Tingting Wang
Qiaofeng Zhang
Shaofang Shu
Xiangdong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536663

451 views

Review

Published on 07 Mar 2025

Medication nonadherence - definition, measurement, prevalence, and causes: reflecting on the past 20 years and looking forwards

in Drugs Outcomes Research and Policies

Sarah C. E. Chapman
Amy H. Y. Chan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1465059

672 views

Original Research

Published on 07 Mar 2025

Clinical–pharmaceutical assessment of medication CDSS alerts: content appropriateness and patient relevance in clinical practice

in Drugs Outcomes Research and Policies

Jacqueline Bauer
Marika Busse
Sonja Koch
Marina Schmid
Julia Sommer
Martin F. Fromm
Frank Dörje

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1510425

747 views

Original Research

Published on 06 Mar 2025

Targeting glycolysis in esophageal squamous cell carcinoma: single-cell and multi-omics insights for risk stratification and personalized therapy

in Drugs Outcomes Research and Policies

Yan Wang
Yunjie Shi
Xiao Hu
Chenfang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559546

762 views

Original Research

Published on 04 Mar 2025

Post-marketing safety re-evaluation of placental peptide injection in China: a large-scale multicenter real-world study

in Drugs Outcomes Research and Policies

Liguang Duan
Feiyue An
Chen Tian
Wen Yan
Jie Chen
Hongyin Zhang
Xiaoguang Liu
Lingjiao Wang
Zhuo Zhang
Binliang Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541005

451 views